Indaptus Therapeutics, Inc. (INDP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2.18M | 9.31M | 6.44M | 6.41M | 4.96M | 6.62M | 7.63M | 7.49M | 10.29M | 14M | 16.84M | 19.87M |
| Cash & Short-Term Investments | 1.5M | 8.51M | 5.83M | 6.16M | 3.89M | 5.79M | 7.38M | 7.3M | 9.74M | 13.36M | 15.96M | 19.69M |
| Cash Only | 1.5M | 8.51M | 5.83M | 6.16M | 3.89M | 5.79M | 7.38M | 7.3M | 9.74M | 13.36M | 15.96M | 12.7M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.99M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 2.7K | 0 | 0 | 12.14K | 0 | 0 | 0 | 19.46K | 32.1K |
| Total Non-Current Assets | 0 | 0 | 401.06K | 426.15K | 450.69K | 720.43K | 610.38K | 633.36K | 655.85K | 928.67K | 950.53K | 971.95K |
| Property, Plant & Equipment | 0 | 0 | 8.49K | 33.58K | 58.12K | 82.17K | 105.66K | 128.63K | 151.12K | 173.94K | 195.81K | 217.22K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 392.57K | 392.57K | 392.57K | 638.25K | 504.73K | 504.73K | 504.73K | 754.73K | 754.73K | 754.73K |
| Total Assets | 2.18M | 9.31M | 6.84M | 6.84M | 5.41M | 7.34M | 8.24M | 8.12M | 10.95M | 14.92M | 17.79M | 20.84M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -59.7% | 26.86% | -16.99% | -15.79% | -50.57% | -50.83% | -53.69% | -61.04% | -52.7% | -46.82% | -41.57% | -38.8% |
| Total Current Liabilities | 933K | 6.16M | 2.23M | 8.51M | 2.61M | 3.39M | 2.23M | 1.93M | 1.54M | 2.77M | 2.37M | 2.1M |
| Accounts Payable | 557.37K | 544.06K | 707.42K | 618.51K | 1.31M | 870.23K | 555.95K | 416.56K | 405.46K | 806K | 617.27K | 747.67K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 6.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 375.63K | 5.61M | 1.52M | 0 | 83.47K | 0 | 0 | 679.35K | 374.45K | 1.21M | 0 | 0 |
| Current Ratio | 2.34x | 1.51x | 2.88x | 0.75x | 1.90x | 1.95x | 3.42x | 3.88x | 6.70x | 5.05x | 7.12x | 9.45x |
| Quick Ratio | 2.34x | 1.51x | 2.88x | 0.75x | 1.90x | 1.95x | 3.42x | 3.88x | 6.70x | 5.05x | 7.12x | 9.45x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 4.01K | 27.58K | 50.66K | 73.35K | 95.24K | 116.17K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 4.01K | 27.58K | 50.66K | 73.35K | 95.24K | 116.17K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 933K | 6.16M | 2.23M | 8.51M | 2.61M | 3.39M | 2.24M | 1.96M | 1.59M | 2.85M | 2.46M | 2.22M |
| Total Debt | 0 | 0 | 8.69K | 6.54M | 59.51K | 84.16K | 107.99K | 130.8K | 153.13K | 175.05K | 196.24K | 216.59K |
| Net Debt | -1.5M | -8.51M | -5.82M | 379.18K | -3.83M | -5.7M | -7.27M | -7.17M | -9.59M | -13.19M | -15.77M | -12.48M |
| Debt / Equity | - | - | 0.00x | - | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.25M | 3.15M | 4.61M | -1.67M | 2.8M | 3.94M | 6M | 6.17M | 9.36M | 12.08M | 15.33M | 18.63M |
| Equity Growth % | -55.43% | -20.11% | -23.28% | -127.14% | -70.09% | -67.33% | -60.85% | -66.89% | -55.82% | -50.97% | -44.38% | -38.75% |
| Book Value per Share | 0.58 | 1.45 | 0.80 | -0.29 | 0.30 | 0.42 | 0.63 | 0.72 | 1.11 | 1.44 | 1.83 | 2.22 |
| Total Shareholders' Equity | 1.25M | 3.15M | 4.61M | -1.67M | 2.8M | 3.94M | 6M | 6.17M | 9.36M | 12.08M | 15.33M | 18.63M |
| Common Stock | 1.13M | 21.67K | 16.42K | 6.05K | 160.34K | 120.14K | 101.97K | 85.53K | 85.39K | 84.01K | 84.01K | 84.01K |
| Retained Earnings | -83.83M | -81.29M | -73.18M | -70.2M | -64.97M | -60.44M | -56.31M | -53.24M | -49.22M | -45.42M | -41.41M | -37.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 134.16K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |